Human T cell responses to Japanese encephalitis virus in health and disease

Journal of Experimental Medicine

Volumn 213, Issue 7, 2016, Pages 1331-1352

  Turtle, Lance ^a,b   Bali, Tanushka ^c   Buxton, Gemma ^a   Chib, Savita ^c   Chan, Sajesh ^c   Soni, Mohammed ^c   Hussain, Mohammed ^d   Isenman, Heather ^a   Fadnis, Prachi ^e   Venkataswamy, Manjunatha M ^e   Satishkumar, Vishali ^d   Lewthwaite, Penny ^f   Kurioka, Ayako ^g   Krishna, Srinivasa ^d   Shankar, M Veera ^d   Ahmed, Riyaz ^d   Begum, Ashia ^d   Ravi, Vasanthapuram ^e   Desai, Anita ^e   Yoksan, Sutee ^h   Fernandez, Stefan ⁱ   Willberg, Christian B ^g   Kloverpris, Henrik N ^g   Conlon, Christopher ^g   Klenerman, Paul ^g   Satchidanandam, Vijaya ^c   Solomon, Tom ^a,j   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d Vijayanagar Institute of Medical Sciences   (India)

^e NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^f ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^j THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; VIRUS PROTEIN; IFNG PROTEIN, HUMAN; NS1 PROTEIN, FLAVIVIRUS; VIRAL PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL EXPANSION; CHILD; CONTROLLED STUDY; CONVALESCENCE; CROSS PROTECTION; CROSS REACTION; CYTOTOXICITY ASSAY; DENGUE VIRUS; ENCEPHALITIS; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PEPTIDE LIBRARY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TARGETING; CLINICAL TRIAL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CROSS REACTIONS; DENGUE VIRUS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; MALE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84977658045     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151517     Document Type: Article

References (64)

1. + T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity. J. Virol. 72:8032-8036.
2. + T cell response. J. Immunol. 183:7919-7930. http://dx.doi.org/10.4049./jimmunol.0803903.
3. Anderson, K.B., R.V. Gibbons, S.J. Thomas, A.L. Rothman, A. Nisalak, R.L. Berkelman, D.H. Libraty, and T.P. Endy. 2011. Preexisting Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in Thailand. PLoS Negl. Trop. Dis. 5:e1311. http://dx.doi.org/10.1371/journal.pntd.0001311.
4. Appanna, R., T.L. Huat, L.L. See, P.L. Tan, J. Vadivelu, and S. Devi. 2007. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia. Clin. Vaccine Immunol. 14:969-977. http://dx.doi.org/10.1128./CVI.00069-07.
5. Ashok, M.S., and P.N. Rangarajan. 1999. Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies. Vaccine. 18:68-75. http://dx.doi.org/10.1016/S0264-410X(99)00180-2.
6. Barnes, E., A. Folgori, S. Capone, L. Swadling, S. Aston, A. Kurioka, J. Meyer, R. Huddart, K. Smith, R. Townsend, et al. 2012. Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man. Sci. Transl. Med. 4:115ra1. http://dx.doi.org/10.1126/scitranslmed.3003155.
7. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods. 281:65-78. http://dx.doi.org/10.1016/S0022-1759(03)00265-5.
8. + T cells. Blood. 107:4781-4789. http://dx.doi.org/10.1182/blood-2005-12-4818.
9. Campbell, G.L., S.L. Hills, M. Fischer, J.A. Jacobson, C.H. Hoke, J.M. Hombach, A.A. Marfin, T. Solomon, T.F. Tsai, V.D. Tsu, and A.S. Ginsburg. 2011. Estimated global incidence of Japanese encephalitis: a systematic review. Bull. World Health Organ. 89:766-774. http://dx.doi.org/10.2471/BLT.10.085233.
10. Chaturvedi, U.C., A. Mathur, P. Tandon, S.M. Natu, S. Rajvanshi, and H.O. Tandon. 1979. Variable effect on peripheral blood leucocytes during JE virus infection of man. Clin. Exp. Immunol. 38:492-498.
11. Draenert, R., M. Altfeld, C. Brander, N. Basgoz, C. Corcoran, A.G. Wurcel, D.R. Stone, S.A. Kalams, A. Trocha, M.M. Addo, et al. 2003. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J. Immunol. Methods. 275:19-29. http://dx.doi.org/10.1016/S0022-1759(02)00541-0.
12. Draenert, R., C. Brander, X.G. Yu, M. Altfeld, C.L. Verrill, M.E. Feeney, B.D. Walker, and P.J. Goulder. 2004. Impact of intrapeptide epitope location on CD8 T cell recognition: implications for design of overlapping peptide panels. AIDS. 18:871-876. http://dx.doi.org/10.1097/00002030-200404090-00004.
13. Duangchinda, T., W. Dejnirattisai, S. Vasanawathana, W. Limpitikul, N. Tangthawornchaikul, P. Malasit, J. Mongkolsapaya, and G. Screaton. 2010. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Proc. Natl. Acad. Sci. USA. 107:16922-16927. http://dx.doi.org/10.1073/pnas.1010867107.
14. Edelman, R., R.J. Schneider, P. Chieowanich, R. Pornpibul, and P. Voodhikul. 1975. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J. Trop. Med. Public Health. 6:308-315.
15. Erup Larsen, M., H. Kloverpris, A. Stryhn, C.K. Koofhethile, S. Sims, T. Ndung'u, P. Goulder, S. Buus, and M. Nielsen. 2011. HLArestrictor-a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides. Immunogenetics. 63:43-55. http://dx.doi.org/10.1007/s00251-010-0493-5.
16. Friberg, H., H. Bashyam, T. Toyosaki-Maeda, J.A. Potts, T. Greenough, S. Kalayanarooj, R.V. Gibbons, A. Nisalak, A. Srikiatkhachorn, S. Green, et al. 2011a. Cross-reactivity and expansion of dengue-specific T cells during acute primary and secondary infections in humans. Sci. Rep. 1:51. http://dx.doi.org/10.1038/srep00051.
17. + T cells from naturally acquired primary dengue virus infection are highly cross-reactive. Immunol. Cell Biol. 89:122-129. http://dx.doi.org/10.1038/icb.2010.61.
18. Gao, N., W. Chen, Q. Zheng, D.Y. Fan, J.L. Zhang, H. Chen, G.F. Gao, D.S. Zhou, and J. An. 2010. Co-expression of Japanese encephalitis virus prME-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination. Immunol. Lett. 129:23-31. http://dx.doi.org/10.1016/j.imlet.2009.12.023.
19. Garcia-Boronat, M., C.M. Diez-Rivero, E.L. Reinherz, and P.A. Reche. 2008. PVS: a web server for protein sequence variability analysis tuned to facilitate conserved epitope discovery. Nucleic Acids Res. 36:W35-W41. http://dx.doi.org/10.1093/nar/gkn211.
20. Gouy, M., S. Guindon, and O. Gascuel. 2010. SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27:221-224. http://dx.doi.org/10.1093/molbev/msp259.
21. Halstead, S.B., and C.R. Grosz. 1962. Subclinical Japanese encephalitis. I. Infection of Americans with limited residence in Korea. Am. J. Hyg. 75:190-201.
22. Hanekom, W.A., J. Hughes, M. Mavinkurve, M. Mendillo, M. Watkins, H. Gamieldien, S.J. Gelderbloem, M. Sidibana, N. Mansoor, V. Davids, et al. 2004. Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. J. Immunol. Methods. 291:185-195. http://dx.doi.org/10.1016/j.jim.2004.06.010.
23. Hatch, S., T.P. Endy, S. Thomas, A. Mathew, J. Potts, P. Pazoles, D.H. Libraty, R. Gibbons, and A.L. Rothman. 2011. Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection. J. Infect. Dis. 203:1282-1291. http://dx.doi.org/10.1093/infdis/jir012.
24. Hoke, C.H.A., A. Nisalak, N. Sangawhipa, S. Jatanasen, T. Laorakapongse, B.L. Innis, S. Kotchasenee, J.B. Gingrich, J. Latendresse, K. Fukai, et al. 1988. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:608-614. http://dx.doi.org/10.1056/NEJM198809083191004.
25. Konishi, E., I. Kurane, P.W. Mason, B.L. Innis, and F.A. Ennis. 1995. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53:278-283.
26. Konishi, E., I. Kurane, P.W. Mason, R.E. Shope, N. Kanesa-Thasan, J.J. Smucny, C.H. Hoke Jr., and F.A. Ennis. 1998. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by poxvirus-based JE vaccine candidates. Vaccine. 16:842-849. http://dx.doi.org/10.1016./S0264-410X(97)00265-X
27. Konishi, E., M. Yamaoka, Khin-Sane-Win, I. Kurane, K. Takada, and P.W. Mason. 1999. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes. J. Virol. 73:5527-5534.
28. + T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J. Gen. Virol. 85:471-482. http://dx.doi.org/10.1099/vir.0.19531-0.
29. Kumar, P., P. Sulochana, G. Nirmala, R. Chandrashekar, M. Haridattatreya, and V. Satchidanandam. 2004b. Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae. J. Infect. Dis. 189:880-891. http://dx.doi.org/10.1086/381768.
30. + T cells in a healthy Japanese encephalitis virus-endemic cohort. J. Gen. Virol. 85:1131-1143. http://dx.doi.org/10.1099/vir.0.19698-0.
31. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J. Virol. 65:1823-1828.
32. Kurioka, A., J.E. Ussher, C. Cosgrove, C. Clough, J.R. Fergusson, K. Smith, Y.H. Kang, L.J. Walker, T.H. Hansen, C.B. Willberg, and P. Klenerman. 2015. MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets. Mucosal Immunol. 8:429-440. http://dx.doi.org/10.1038/mi.2014.81.
33. + T cells to recovery from infection in a murine model of Japanese encephalitis. J. Virol. 85:5446-5455. http://dx.doi.org/10.1128/JVI.02611-10.
34. Larena, M., M. Regner, and M. Lobigs. 2013. Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitis. Eur. J. Immunol. 43:1789-1798. http://dx.doi.org/10.1002/eji.201243152.
35. Larkin, M.A., G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, R. Lopez, et al. 2007. Clustal W and Clustal X version 2.0. Bioinformatics. 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/btm404.
36. Lewthwaite, P., A. Begum, M.H. Ooi, B. Faragher, B.F. Lai, I. Sandaradura, A. Mohan, G. Mandhan, P. Meharwade, S. Subhashini, et al. 2010a. Disability after encephalitis: development and validation of a new outcome score. Bull. World Health Organ. 88:584-592. http://dx.doi.org/10.2471/BLT.09.071357.
37. Lewthwaite, P., D. Perera, M.H. Ooi, A. Last, R. Kumar, A. Desai, A. Begum, V. Ravi, M.V. Shankar, P.H. Tio, et al. 2010b. Enterovirus 75 encephalitis in children, southern India. Emerg. Infect. Dis. 16:1780-1782. http://dx.doi.org/10.3201/eid1611.100672.
38. Lewthwaite, P., M.V. Shankar, P.H. Tio, J. Daly, A. Last, R. Ravikumar, A. Desai, V. Ravi, J.M. Cardosa, and T. Solomon. 2010c. Evaluation of two commercially available ELI SAs for the diagnosis of Japanese encephalitis applied to field samples. Trop. Med. Int. Health. 15:811-818. http://dx.doi.org/10.1111/j.1365-3156.2010.02537.x
39. Libraty, D.H., A. Nisalak, T.P. Endy, S. Suntayakorn, D.W. Vaughn, and B.L. Innis. 2002. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 96:173-178. http://dx.doi.org/10.1016/S0035-9203(02)90294-4.
40. Lubiniecki, A.S., R.H. Cypess, and W.M. Hammon. 1973. Passive immunity for arbovirus infection. II. Quantitative aspects of naturally and artificially acquired protection in mice for Japanese (B) encephalitis virus. Am. J. Trop. Med. Hyg. 22:535-542.
41. Mackowiak, P.A., S.S. Wasserman, and M.M. Levine. 1992. A critical appraisal of 98.6°F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA. 268:1578-1580. http://dx.doi.org/10.1001/jama.1992.03490120092034.
42. Mongkolsapaya, J., W. Dejnirattisai, X.N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9:921-927. http://dx.doi.org/10.1038/nm887.
43. Murali-Krishna, K., V. Ravi, and R. Manjunath. 1994. Cytotoxic T lymphocytes raised against Japanese encephalitis virus: effector cell phenotype, target specificity and in vitro virus clearance. J. Gen. Virol. 75:799-807. http://dx.doi.org/10.1099/0022-1317-75-4-799.
44. + T cells. J. Gen. Virol. 77:705-714. http://dx.doi.org/10.1099/0022-1317-77-4-705.
45. Pardo, J., A. Bosque, R. Brehm, R. Wallich, J. Naval, A. Müllbacher, A. Anel, and M.M. Simon. 2004. Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis. J. Cell Biol. 167:457-468. http://dx.doi.org/10.1083/jcb.200406115.
46. Parker, K.C., M.A. Bednarek, and J.E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163-175.
47. + T cell epitopes. J. Immunol. 181:1563-1572. http://dx.doi.org/10.4049/jimmunol.181.2.1563.
48. Piazza, P., C.P. McMurtrey, A. Lelic, R.L. Cook, R. Hess, E. Yablonsky, L. Borowski, M.B. Loeb, J.L. Bramson, W.H. Hildebrand, and C.R. Rinaldo. 2010. Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS One. 5:e15343. http://dx.doi.org/10.1371/journal.pone.0015343.
49. Pickett, B.E., E.L. Sadat, Y. Zhang, J.M. Noronha, R.B. Squires, V. Hunt, M. Liu, S. Kumar, S. Zaremba, Z. Gu, et al. 2012. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 40:D593-D598. http://dx.doi.org/10.1093/nar/gkr859.
50. Rammensee, H., J. Bachmann, N.P. Emmerich, O.A. Bachor, and S. Stevanovic. 1999. SYF PEI THI: database for MHC ligands and peptide motifs. Immunogenetics. 50:213-219. http://dx.doi.org/10.1007/s002510050595.
51. + T lymphocytes in dengue virus infection. J. Virol. 87:2693-2706. http://dx.doi.org/10.1128/JVI.02675-12.
52. Roederer, M., J.L. Nozzi, and M.C. Nason. 2011. SPI CE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A. 79A:167-174. http://dx.doi.org/10.1002/cyto.a.21015.
53. Rothman, A.L. 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr. Top. Microbiol. Immunol. 338:83-98. http://dx.doi.org/10.1007/978-3-642-02215-97.
54. Russell, P.K., A. Nisalak, P. Sukhavachana, and S. Vivona. 1967. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99:285-290.
55. Seder, R.A., P.A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8:247-258. http://dx.doi.org/10.1038/nri2274.
56. Solomon, T. 2004. Flavivirus encephalitis. N. Engl. J. Med. 351:370-378. http://dx.doi.org/10.1056/NEJMra030476.
57. Solomon, T., N.M. Dung, R. Kneen, T.T. Thao, M. Gainsborough, A. Nisalak, N.P. Day, F.J. Kirkham, D.W. Vaughn, S. Smith, and N.J. White. 2002. Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis. Brain. 125:1084-1093. http://dx.doi.org/10.1093/brain/awf116.
58. Sumiyoshi, H., C. Mori, I. Fuke, K. Morita, S. Kuhara, J. Kondou, Y. Kikuchi, H. Nagamatu, and A. Igarashi. 1987. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology. 161:497-510. http://dx.doi.org/10.1016/0042-6822(87)90144-9.
59. Van Gessel, Y., C.S. Klade, R. Putnak, A. Formica, S. Krasaesub, M. Spruth, B. Cena, A. Tungtaeng, M. Gettayacamin, and S. Dewasthaly. 2011. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXI ARO®) induced neutralizing antibody titers. Vaccine. 29:5925-5931. http://dx.doi.org/10.1016/j.vaccine.2011.06.062.
60. Watt, G., and K. Jongsakul. 2003. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am. J. Trop. Med. Hyg. 68:704-706.
61. + T cells. Proc. Natl. Acad. Sci. USA. 110:E2046-E2053. http://dx.doi.org/10.1073/pnas.1305227110.
62. + T-cell responses against the 4 Dengue virus serotypes are associated with distinct patterns of protein targets. J. Infect. Dis. 212:1743-1751. http://dx.doi.org/10.1093/infdis/jiv289.
63. Welsh, R.M., J.W. Che, M.A. Brehm, and L.K. Selin. 2010. Heterologous immunity between viruses. Immunol. Rev. 235:244-266. http://dx.doi.org/10.1111/j.0105-2896.2010.00897.x
64. Winter, P.M., N.M. Dung, H.T. Loan, R. Kneen, B. Wills, T. Thu, D. House, N.J. White, J.J. Farrar, C.A. Hart, and T. Solomon. 2004. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J. Infect. Dis. 190:1618-1626. http://dx.doi.org/10.1086/423328.